Ekso Bionics (EKSO) Misses Q4 EPS by 5c
Tweet
Share
E-mailGet Alerts EKSO Hot Sheet
Join SI Premium – FREE
Ekso Bionics (NASDAQ: EKSO) reported Q4 EPS of ($0.14), $0.05 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $5.1 million versus the consensus estimate of $6.05 million.
For earnings history and earnings-related data on Ekso Bionics (EKSO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Barclays Starts Hawkins (HWKN) at Equalweight
- Barclays Starts Zurn Water Solutions (ZWS) at Overweight
- Barclays Starts Mueller Water Products (MWA) at Underweight
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
